News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
788,508 Results
Type
Article (71746)
Company Profile (792)
Press Release (715956)
Multimedia
Podcasts (160)
Webinars (24)
Section
Business (209549)
Career Advice (3319)
Deals (37635)
Drug Delivery (138)
Drug Development (85314)
Employer Resources (178)
FDA (17321)
Job Trends (16597)
News (361105)
Policy (35753)
Tag
Academia (2951)
Academic (2)
Accelerated approval (30)
Adcomms (30)
Allergies (137)
Alliances (51877)
ALS (173)
Alzheimer's disease (1736)
Antibody-drug conjugate (ADC) (292)
Approvals (17502)
Artificial intelligence (522)
Autoimmune disease (135)
Automation (33)
Bankruptcy (352)
Best Places to Work (12553)
BIOSECURE Act (23)
Biosimilars (190)
Biotechnology (464)
Bladder cancer (151)
Brain cancer (59)
Breast cancer (626)
Cancer (4685)
Cardiovascular disease (402)
Career advice (2823)
Career pathing (40)
CAR-T (293)
CDC (58)
Celiac Disease (1)
Cell therapy (764)
Cervical cancer (37)
Clinical research (72031)
Collaboration (1606)
Company closure (5)
Compensation (1091)
Complete response letters (60)
COVID-19 (2875)
CRISPR (92)
C-suite (752)
Cystic fibrosis (148)
Data (5942)
Decentralized trials (2)
Denatured (45)
Depression (127)
Diabetes (480)
Diagnostics (7119)
Digital health (40)
Diversity (12)
Diversity, equity & inclusion (42)
Drug discovery (250)
Drug pricing (201)
Drug shortages (33)
Duchenne muscular dystrophy (223)
Earnings (84652)
Editorial (58)
Employer branding (21)
Employer resources (154)
Events (126455)
Executive appointments (1010)
FDA (20270)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (21)
Funding (1441)
Gene editing (201)
Generative AI (45)
Gene therapy (602)
GLP-1 (1025)
Government (5229)
Grass and pollen (8)
Guidances (380)
Healthcare (20817)
HIV (54)
Huntington's disease (41)
IgA nephropathy (76)
Immunology and inflammation (252)
Immuno-oncology (42)
Indications (79)
Infectious disease (3143)
Inflammatory bowel disease (197)
Inflation Reduction Act (16)
Influenza (113)
Intellectual property (227)
Interviews (625)
IPO (17768)
IRA (59)
Job creations (4483)
Job search strategy (2336)
Kidney cancer (16)
Labor market (81)
Layoffs (634)
Leadership (37)
Legal (8439)
Liver cancer (93)
Longevity (12)
Lung cancer (636)
Lymphoma (363)
Machine learning (38)
Management (63)
Manufacturing (746)
MASH (166)
Medical device (14838)
Medtech (14879)
Mergers & acquisitions (20925)
Metabolic disorders (1246)
Multiple sclerosis (148)
NASH (21)
Neurodegenerative disease (302)
Neuropsychiatric disorders (83)
Neuroscience (2913)
NextGen: Class of 2025 (7547)
Non-profit (5082)
Now hiring (40)
Obesity (583)
Opinion (318)
Ovarian cancer (155)
Pain (193)
Pancreatic cancer (210)
Parkinson's disease (272)
Partnered (34)
Patents (475)
Patient recruitment (430)
Peanut (59)
People (64525)
Pharmaceutical (139)
Pharmacy benefit managers (29)
Phase I (22361)
Phase II (31414)
Phase III (23661)
Pipeline (4121)
Policy (310)
Postmarket research (3005)
Preclinical (9838)
Press Release (71)
Prostate cancer (229)
Psychedelics (50)
Radiopharmaceuticals (289)
Rare diseases (803)
Real estate (6975)
Recruiting (73)
Regulatory (26358)
Reports (46)
Research institute (2673)
Resumes & cover letters (517)
Rett syndrome (24)
RNA editing (15)
RSV (79)
Schizophrenia (150)
Series A (242)
Series B (179)
Service/supplier (29)
Sickle cell disease (101)
Special edition (24)
Spinal muscular atrophy (168)
Sponsored (45)
Startups (3888)
State (2)
Stomach cancer (16)
Supply chain (107)
Tariffs (91)
The Weekly (113)
Vaccines (1052)
Venture capital (80)
Weight loss (388)
Women's health (70)
Worklife (21)
Date
Today (19)
Last 7 days (122)
Last 30 days (1962)
Last 365 days (32319)
2026 (19)
2025 (32311)
2024 (37528)
2023 (42261)
2022 (53563)
2021 (58513)
2020 (57484)
2019 (51053)
2018 (38751)
2017 (35158)
2016 (34974)
2015 (40950)
2014 (34985)
2013 (32893)
2012 (32458)
2011 (32698)
2010 (31665)
Location
Africa (1069)
Alabama (85)
Alaska (7)
Arizona (282)
Arkansas (14)
Asia (46020)
Australia (8175)
California (10905)
Canada (3176)
China (1074)
Colorado (457)
Connecticut (483)
Delaware (328)
Europe (107188)
Florida (1607)
Georgia (354)
Hawaii (3)
Idaho (67)
Illinois (877)
India (61)
Indiana (522)
Iowa (22)
Japan (397)
Kansas (128)
Kentucky (41)
Louisiana (29)
Maine (81)
Maryland (1397)
Massachusetts (8069)
Michigan (335)
Minnesota (636)
Mississippi (6)
Missouri (135)
Montana (34)
Nebraska (28)
Nevada (118)
New Hampshire (81)
New Jersey (2981)
New Mexico (31)
New York (2919)
North Carolina (1539)
North Dakota (10)
Northern California (5174)
Ohio (331)
Oklahoma (22)
Oregon (52)
Pennsylvania (2214)
Puerto Rico (20)
Rhode Island (48)
South America (1408)
South Carolina (61)
South Dakota (1)
Southern California (4206)
Tennessee (169)
Texas (1711)
United States (39586)
Utah (328)
Vermont (1)
Virginia (276)
Washington D.C. (85)
Washington State (929)
West Virginia (4)
Wisconsin (115)
Wyoming (2)
788,508 Results for "lyophilization services of new england".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaderis Therapeutics Announces The New England Journal of Medicine Publishes Engasertib Proof-of-Concept and Long-Term Extension Results, Highlighting the Therapy’s Potential for Patients with Hereditary Hemorrhagic Telangiectasia
December 3, 2025
·
4 min read
Press Releases
The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)
December 30, 2025
·
12 min read
Press Releases
Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease
December 8, 2025
·
6 min read
Press Releases
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
November 24, 2025
·
3 min read
Press Releases
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
December 8, 2025
·
11 min read
Press Releases
The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
December 4, 2025
·
13 min read
Press Releases
Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients
October 29, 2025
·
6 min read
Press Releases
Encouraging Results from a First-in-Human Phase 1 Clinical Trial of IAVI’s Lassa Vaccine Candidate Published in New England Journal of Medicine
November 7, 2025
·
10 min read
Press Releases
Vor Bio Announces Publication of China Phase 3 Study of Telitacicept in Systemic Lupus Erythematosus in The New England Journal of Medicine
October 17, 2025
·
7 min read
Press Releases
Vera Therapeutics Announces Positive ORIGIN Phase 3 Data for Atacicept in IgA Nephropathy Presented at ASN Kidney Week 2025 and Published in the New England Journal of Medicine
November 7, 2025
·
9 min read
1 of 78,851
Next
